The News Journal of Wilmington reported Saturday (http://delonline.us/2hcV1sr ) that Incyte will pay about $120 million to Merus, a Dutch developer of cancer medicines. The company will also spend $80 million to buy Merus stock. That will …
"We really think Incyte has proved itself to be the commercially viable ... company Wednesday announced a $422 million private placement of 2 million shares of its common stock at $211 per share to selected institutional investors. Tang …
Incyte currently carries a Zacks Rank #3 (Hold). Bristol-Myers Squibb Company BMY is a better-ranked stock in the health care sector with a Zacks Rank #1 (Strong Buy). Want the latest recommendations from Zacks Investment …
On December 21, genomic-content provider Incyte Genomics (Palo Alto, CA) agreed to acquire privately held Proteome (Beverly, MA) for $77 million in cash and stock. The merger adds annotation and reference data from Proteome's …
Incyte Corp (NASDAQ:INCY) traded in a range yesterday that spanned from a low of $92.65 to a high of $95.33. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $93.58 on volume of 770,000 …
Below are the earnings highlights for Incyte Corporation (INCY): -Earnings: -$12.48 million in Q2 vs. $34.43 million in the same period last year. -EPS: -$0.06 in Q2 vs. $0.18 in the same period last year. -Analysts projected -$0.03 per share …
Are you ready for the cold dark days that come with Daylight Saving Time? Prepare for winter skin before turning your clock back on Sunday. To Lose Weight, Skip Dinner A Few Days A Week New research suggests that skipping dinner helps …
; for The Day Ahead newsletter http://link.reuters.com/mex49s; was down 10.44 points, or 0.67 percent. The Nasdaq Composite Index was down 21.43 points, or 0.66 percent.
Incyte Corporation (NASDAQ:INCY)‘s stock on Friday traded at beginning with a price of $ 85.55 and when day-trade ended the stock finally moved up 0.51% to reach at $86.03. Analyst’s mean target price for INCY is $143.26 while …